Benelux site
A collaborative and experienced partner
We partner with innovative pharma, digital health ‘pioneers’, tech platforms, distributors and suppliers who share our goal to sustainably improve the patient experience and communities they are part of.
The life cycle
management company
Learn more
Committed to realising the full potential of established medicines
We use patient and clinician insights to identify areas of ongoing unmet need, then use our expertise as a leader in life cycle management to find innovative ways to deliver better outcomes for patients.
More about usWhat's new
Our portfolio
Cardiovascular
Our key products include Inderal®, Tenormin®, Tenoretic®, Zestril®and Zestoretic®
Endocrinology
Our key products include Bonviva®, Rocaltrol® and Synacthen®
Neurology
Our key products include Anaprox®, Naprosyn®, Toradol® and Valium®
Oncology
Our key products include Bondronat®, Dipentum® and Kytril®
Our numbers
-
15+
Offices
-
25+
Brands
-
160+
Markets
-
320+
Employees
A team of inquisitive minds
Pharmanovia’s success is down to its people. Our inclusive, high-performance culture provides opportunities to continually learn, develop and make change happen.
Latest news
1st April 2025
Pharmanovia acquires exclusive rights to novel antipsychotic treatment
BASILDON, UK, 1st April 2025 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...
More information
21st February 2025
Pharmanovia announces exclusive distribution agreement with Er-Kim for Sunosi® in Eastern Europe
PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY Basildon, UK – 21 February 2025 Pharmanovia,...
More information
14th February 2025
Lindis Biotech and Pharmanovia announce European marketing authorisation approval for a first-in-class treatment
PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY MUNICH, GERMANY, AND BASILDON, UK, 13 February...
More informationOur memberships
We are proud to be a member of Medicines for Europe.
